NET formation-mediated in situ protein delivery to the inflamed central nervous system

Abstract Delivering protein drugs to the central nervous system (CNS) is challenging due to the blood-brain and blood-spinal cord barrier. Here we show that neutrophils, which naturally migrate through these barriers to inflamed CNS sites and release neutrophil extracellular traps (NETs), can be lev...

Full description

Saved in:
Bibliographic Details
Main Authors: Yina Wu, Jinwon Park, Quoc-Viet Le, Junho Byun, Jaehyun Choi, Enzhen Xu, Jaiwoo Lee, Yu-Kyoung Oh
Format: Article
Language:English
Published: Nature Portfolio 2024-12-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-024-54817-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585556499890176
author Yina Wu
Jinwon Park
Quoc-Viet Le
Junho Byun
Jaehyun Choi
Enzhen Xu
Jaiwoo Lee
Yu-Kyoung Oh
author_facet Yina Wu
Jinwon Park
Quoc-Viet Le
Junho Byun
Jaehyun Choi
Enzhen Xu
Jaiwoo Lee
Yu-Kyoung Oh
author_sort Yina Wu
collection DOAJ
description Abstract Delivering protein drugs to the central nervous system (CNS) is challenging due to the blood-brain and blood-spinal cord barrier. Here we show that neutrophils, which naturally migrate through these barriers to inflamed CNS sites and release neutrophil extracellular traps (NETs), can be leveraged for therapeutic delivery. Tannic acid nanoparticles tethered with anti-Ly6G antibody and interferon-β (aLy6G-IFNβ@TLP) are constructed for targeted neutrophil delivery. These nanoparticles protect interferon-β from reactive oxygen species and preferentially accumulate in neutrophils over other immune cells. Upon encountering inflammation, neutrophils release the nanoparticles during NET formation. In the female mouse model of experimental autoimmune encephalomyelitis, intravenous administration of aLy6G-IFNβ@TLP reduce disease progression and restore motor function. Although this study focuses on IFNβ and autoimmune encephalomyelitis, the concept of hitchhiking neutrophils for CNS delivery and employing NET formation for inflamed site-specific nanoparticle release can be further applied for delivery of other protein drugs in the treatment of neurodegenerative diseases.
format Article
id doaj-art-374f8a05bee34df1a383708b368ee2de
institution Kabale University
issn 2041-1723
language English
publishDate 2024-12-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj-art-374f8a05bee34df1a383708b368ee2de2025-01-26T12:40:09ZengNature PortfolioNature Communications2041-17232024-12-0115111610.1038/s41467-024-54817-7NET formation-mediated in situ protein delivery to the inflamed central nervous systemYina Wu0Jinwon Park1Quoc-Viet Le2Junho Byun3Jaehyun Choi4Enzhen Xu5Jaiwoo Lee6Yu-Kyoung Oh7College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National UniversityCollege of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National UniversityFaculty of Pharmacy, Ton Duc Thang UniversityCollege of Pharmacy, Sookmyung Women’s UniversityCollege of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National UniversityCollege of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National UniversityCollege of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National UniversityCollege of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National UniversityAbstract Delivering protein drugs to the central nervous system (CNS) is challenging due to the blood-brain and blood-spinal cord barrier. Here we show that neutrophils, which naturally migrate through these barriers to inflamed CNS sites and release neutrophil extracellular traps (NETs), can be leveraged for therapeutic delivery. Tannic acid nanoparticles tethered with anti-Ly6G antibody and interferon-β (aLy6G-IFNβ@TLP) are constructed for targeted neutrophil delivery. These nanoparticles protect interferon-β from reactive oxygen species and preferentially accumulate in neutrophils over other immune cells. Upon encountering inflammation, neutrophils release the nanoparticles during NET formation. In the female mouse model of experimental autoimmune encephalomyelitis, intravenous administration of aLy6G-IFNβ@TLP reduce disease progression and restore motor function. Although this study focuses on IFNβ and autoimmune encephalomyelitis, the concept of hitchhiking neutrophils for CNS delivery and employing NET formation for inflamed site-specific nanoparticle release can be further applied for delivery of other protein drugs in the treatment of neurodegenerative diseases.https://doi.org/10.1038/s41467-024-54817-7
spellingShingle Yina Wu
Jinwon Park
Quoc-Viet Le
Junho Byun
Jaehyun Choi
Enzhen Xu
Jaiwoo Lee
Yu-Kyoung Oh
NET formation-mediated in situ protein delivery to the inflamed central nervous system
Nature Communications
title NET formation-mediated in situ protein delivery to the inflamed central nervous system
title_full NET formation-mediated in situ protein delivery to the inflamed central nervous system
title_fullStr NET formation-mediated in situ protein delivery to the inflamed central nervous system
title_full_unstemmed NET formation-mediated in situ protein delivery to the inflamed central nervous system
title_short NET formation-mediated in situ protein delivery to the inflamed central nervous system
title_sort net formation mediated in situ protein delivery to the inflamed central nervous system
url https://doi.org/10.1038/s41467-024-54817-7
work_keys_str_mv AT yinawu netformationmediatedinsituproteindeliverytotheinflamedcentralnervoussystem
AT jinwonpark netformationmediatedinsituproteindeliverytotheinflamedcentralnervoussystem
AT quocvietle netformationmediatedinsituproteindeliverytotheinflamedcentralnervoussystem
AT junhobyun netformationmediatedinsituproteindeliverytotheinflamedcentralnervoussystem
AT jaehyunchoi netformationmediatedinsituproteindeliverytotheinflamedcentralnervoussystem
AT enzhenxu netformationmediatedinsituproteindeliverytotheinflamedcentralnervoussystem
AT jaiwoolee netformationmediatedinsituproteindeliverytotheinflamedcentralnervoussystem
AT yukyoungoh netformationmediatedinsituproteindeliverytotheinflamedcentralnervoussystem